Discovery of a novel dual EGFR/HER-2 inhibitor

被引：0

作者：

不详

机构：

来源：

PHARMACOGENOMICS | 2010年 / 11卷 / 06期

关键词：

RESISTANCE; GEFITINIB;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：745 / 745

页数：1

共 4 条

[1] Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer [J].

Cha, Mi Young ;

Lee, Kwang-Ok ;

Kim, Jong Woo ;

Lee, Chang Gon ;

Song, Ji Yeon ;

Kim, Young Hoon ;

Lee, Gwan Sun ;

Park, Seung Bum ;

Kim, Maeng Sup .

JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6880-6888

[2] MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling [J].

Engelman, Jeffrey A. ;

Zejnullahu, Kreshnik ;

Mitsudomi, Tetsuya ;

Song, Youngchul ;

Hyland, Courtney ;

Park, Joon Oh ;

Lindeman, Neal ;

Gale, Christopher-Michael ;

Zhao, Xiaojun ;

Christensen, James ;

Kosaka, Takayuki ;

Holmes, Alison J. ;

Rogers, Andrew M. ;

Cappuzzo, Federico ;

Mok, Tony ;

Lee, Charles ;

Johnson, Bruce E. ;

Cantley, Lewis C. ;

Janne, Pasi A. .

SCIENCE, 2007, 316 (5827) :1039-1043

[3] Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib [J].

Kwak, EL ;

Sordella, R ;

Bell, DW ;

Godin-Heymann, N ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Driscoll, DR ;

Fidias, P ;

Lynch, TJ ;

Rabindran, SK ;

McGinnis, JP ;

Wissner, A ;

Sharma, SV ;

Isselbacher, KJ ;

Settleman, J ;

Haber, DA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (21) :7665-7670

[4] HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors [J].

Wang, Shizhen Emily ;

Narasanna, Archana ;

Perez-Torres, Marianela ;

Xiang, Bin ;

Wu, Frederick Y. ;

Yang, Seungchan ;

Carpenter, Graham ;

Gazdar, Adi F. ;

Muthuswamy, Senthil K. ;

Arteaga, Carlos L. .

CANCER CELL, 2006, 10 (01) :25-38

← 1 →